BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31146646)

  • 1. Computational modeling of novel inhibitory peptides targeting proteoglycan like region of carbonic anhydrase IX and
    John A; Sivashanmugam M; Natarajan SK; Umashankar V
    J Biomol Struct Dyn; 2020 Apr; 38(7):1995-2006. PubMed ID: 31146646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual screening, molecular dynamics, and binding free energy calculations on human carbonic anhydrase IX catalytic domain for deciphering potential leads.
    John A; Sivashanmugam M; Umashankar V; Natarajan SK
    J Biomol Struct Dyn; 2017 Aug; 35(10):2155-2168. PubMed ID: 27373313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IX.
    Murri-Plesko MT; Hulikova A; Oosterwijk E; Scott AM; Zortea A; Harris AL; Ritter G; Old L; Bauer S; Swietach P; Renner C
    Eur J Pharmacol; 2011 Apr; 657(1-3):173-83. PubMed ID: 21315712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique epitope-antibody interactions in the intrinsically disordered proteoglycan-like domain of human carbonic anhydrase IX defined by high-resolution NMR combined with yeast surface display.
    Ni F; Wu C; Xu P; Wang P; Fortin Y; Arbour M; Masson L; L'Abbé D; Acel A; Gosselin M; Lenferink AEG
    MAbs; 2023; 15(1):2248672. PubMed ID: 37622732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new peptide ligand for targeting human carbonic anhydrase IX, identified through the phage display technology.
    Askoxylakis V; Garcia-Boy R; Rana S; Krämer S; Hebling U; Mier W; Altmann A; Markert A; Debus J; Haberkorn U
    PLoS One; 2010 Dec; 5(12):e15962. PubMed ID: 21209841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.
    Lou Y; McDonald PC; Oloumi A; Chia S; Ostlund C; Ahmadi A; Kyle A; Auf dem Keller U; Leung S; Huntsman D; Clarke B; Sutherland BW; Waterhouse D; Bally M; Roskelley C; Overall CM; Minchinton A; Pacchiano F; Carta F; Scozzafava A; Touisni N; Winum JY; Supuran CT; Dedhar S
    Cancer Res; 2011 May; 71(9):3364-76. PubMed ID: 21415165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbonic anhydrase IX (CA IX) mediates tumor cell interactions with microenvironment.
    Zavadova Z; Zavada J
    Oncol Rep; 2005 May; 13(5):977-82. PubMed ID: 15809767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of a novel peptide ligand targeting human carbonic anhydrase IX.
    Rana S; Nissen F; Marr A; Markert A; Altmann A; Mier W; Debus J; Haberkorn U; Askoxylakis V
    PLoS One; 2012; 7(5):e38279. PubMed ID: 22693612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsecond Simulation of the Proteoglycan-like Region of Carbonic Anhydrase IX and Design of Chemical Inhibitors Targeting pH Homeostasis in Cancer Cells.
    John A; Vetrivel U; Sivashanmugam M; Natarajan SK
    ACS Omega; 2020 Mar; 5(8):4270-4281. PubMed ID: 32149257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models.
    Ward C; Meehan J; Mullen P; Supuran C; Dixon JM; Thomas JS; Winum JY; Lambin P; Dubois L; Pavathaneni NK; Jarman EJ; Renshaw L; Um IH; Kay C; Harrison DJ; Kunkler IH; Langdon SP
    Oncotarget; 2015 Sep; 6(28):24856-70. PubMed ID: 26259239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic relevance of carbonic anhydrase IX expression is distinct in various subtypes of breast cancer and its silencing suppresses self-renewal capacity of breast cancer cells.
    Ivanova L; Zandberga E; Siliņa K; Kalniņa Z; Ābols A; Endzeliņš E; Vendina I; Romanchikova N; Hegmane A; Trapencieris P; Eglītis J; Linē A
    Cancer Chemother Pharmacol; 2015 Feb; 75(2):235-46. PubMed ID: 25422154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalysis and pH control by membrane-associated carbonic anhydrase IX in MDA-MB-231 breast cancer cells.
    Li Y; Tu C; Wang H; Silverman DN; Frost SC
    J Biol Chem; 2011 May; 286(18):15789-96. PubMed ID: 21454639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of antibody structure upon association to a human carbonic anhydrase IX epitope studied by X-ray crystallography, microcalorimetry, and molecular dynamics simulations.
    Král V; Mader P; Collard R; Fábry M; Horejsí M; Rezácová P; Kozísek M; Závada J; Sedlácek J; Rulísek L; Brynda J
    Proteins; 2008 May; 71(3):1275-87. PubMed ID: 18041760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of the phage display derived peptide CaIX-P1 on human colorectal carcinoma cells correlates with the expression of carbonic anhydrase IX.
    Askoxylakis V; Ehemann V; Rana S; Krämer S; Rahbari NN; Debus J; Haberkorn U
    Int J Mol Sci; 2012 Oct; 13(10):13030-48. PubMed ID: 23202936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs.
    Dubois L; Peeters SG; van Kuijk SJ; Yaromina A; Lieuwes NG; Saraya R; Biemans R; Rami M; Parvathaneni NK; Vullo D; Vooijs M; Supuran CT; Winum JY; Lambin P
    Radiother Oncol; 2013 Sep; 108(3):523-8. PubMed ID: 23849171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH.
    Chiche J; Ilc K; Laferrière J; Trottier E; Dayan F; Mazure NM; Brahimi-Horn MC; Pouysségur J
    Cancer Res; 2009 Jan; 69(1):358-68. PubMed ID: 19118021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotargeting of human cervical carcinoma xenograft expressing CA IX tumor-associated antigen by 125I-labeled M75 monoclonal antibody.
    Chrastina A; Pastoreková S; Pastorek J
    Neoplasma; 2003; 50(1):13-21. PubMed ID: 12687273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies generated in carbonic anhydrase IX-deficient mice recognize different domains of tumour-associated hypoxia-induced carbonic anhydrase IX.
    Zat'ovicová M; Tarábková K; Svastová E; Gibadulinová A; Mucha V; Jakubícková L; Biesová Z; Rafajová M; Ortova Gut M; Parkkila S; Parkkila AK; Waheed A; Sly WS; Horak I; Pastorek J; Pastoreková S
    J Immunol Methods; 2003 Nov; 282(1-2):117-34. PubMed ID: 14604546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
    Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
    Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Small Molecule Tubulysin B Conjugate for Treatment of Carbonic Anhydrase IX Receptor Expressing Cancers.
    Marks IS; Gardeen SS; Kurdziel SJ; Nicolaou ST; Woods JE; Kularatne SA; Low PS
    Mol Pharm; 2018 Jun; 15(6):2289-2296. PubMed ID: 29715036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.